|
MKI67IP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19669999999006E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.253780E-02 |
| Normal-vs-Stage2 |
8.666000E-02 |
| Normal-vs-Stage3 |
1.377430E-03 |
| Normal-vs-Stage4 |
2.755300E-03 |
| Stage1-vs-Stage2 |
5.938200E-01 |
| Stage1-vs-Stage3 |
1.920050E-02 |
| Stage1-vs-Stage4 |
6.260800E-03 |
| Stage2-vs-Stage3 |
1.245630E-01 |
| Stage2-vs-Stage4 |
9.796200E-03 |
| Stage3-vs-Stage4 |
2.441700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.158030E-04 |
| Normal-vs-AfricanAmerican |
1.357820E-02 |
| Normal-vs-Asian |
8.544000E-02 |
| Caucasian-vs-AfricanAmerican |
8.190200E-01 |
| Caucasian-vs-Asian |
5.540100E-02 |
| AfricanAmerican-vs-Asian |
5.618200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.898400E-03 |
| Normal-vs-Female |
6.80219999993348E-07 |
| Male-vs-Female |
1.022140E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.223890E-02 |
| Normal-vs-Extreme_Weight |
1.125580E-02 |
| Normal-vs-Obese |
6.986000E-04 |
| Normal-vs-Extreme_Obese |
9.085000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.849200E-01 |
| Normal_Weight-vs-Obese |
7.124800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.528200E-02 |
| Extreme_Weight-vs-Obese |
8.557800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.002000E-01 |
| Obese-vs-Extreme_Obese |
3.286200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.059900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.147499999967E-06 |
| Normal-vs-Age(61-80Yrs) |
4.353900E-02 |
| Normal-vs-Age(81-100Yrs) |
6.700400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.416200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.064300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.644300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.535900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.364040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.010400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.061600E-02 |
| Normal-VS-Type2 PRCC |
6.343000E-03 |
| Normal-VS-KIRP CIMP |
1.230300E-04 |
| Normal-VS-Unclassified PRCC |
6.647500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.717210E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.581200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.755000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.81849999994588E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
5.628800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.17130000032439E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.190620E-01 |
| Normal-vs-N1 |
2.28749999999778E-05 |
| Normal-vs-N2 |
8.96870000044458E-07 |
| N0-vs-N1 |
1.215790E-04 |
| N0-vs-N2 |
1.637520E-02 |
| N1-vs-N2 |
1.385210E-01 |
|
|
